Author: Xiaohua Chen; Binghong Zhao; Yueming Qu; Yurou Chen; Jie Xiong; Yong Feng; Dong Men; Qianchuan Huang; Ying Liu; Bo Yang; Jinya Ding; Feng Li
Title: Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely associated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients Document date: 2020_3_3
ID: g41pd9uz_32
Snippet: Our research indicated that serum SARS-CoV-2 viral load and IL-6 level could serve as an indicator of poor prognosis. Since the mortality of COVID-19 critically ill patients is considerable, the host-directed therapies should be an option. If IL-6 could become a therapeutic target for treatment of critically ill patient? Notably, the IL-6 monoclonal antibody-directed COVID-19 therapy has been used in clinical trial in China (No.ChiCTR2000029765)......
Document: Our research indicated that serum SARS-CoV-2 viral load and IL-6 level could serve as an indicator of poor prognosis. Since the mortality of COVID-19 critically ill patients is considerable, the host-directed therapies should be an option. If IL-6 could become a therapeutic target for treatment of critically ill patient? Notably, the IL-6 monoclonal antibody-directed COVID-19 therapy has been used in clinical trial in China (No.ChiCTR2000029765). Our data strongly support this notion and efficacy of IL-6 monoclonal antibody directed therapy remains to be fully evaluated.
Search related documents:
Co phrase search for related documents- antibody direct and monoclonal antibody: 1, 2, 3, 4, 5, 6, 7
- antibody direct and monoclonal antibody direct: 1, 2, 3, 4, 5, 6
- antibody direct and viral load: 1, 2, 3, 4, 5, 6, 7
- clinical trial and critically ill patient: 1, 2, 3, 4, 5, 6, 7, 8, 9
- clinical trial and critically ill patient mortality: 1
- clinical trial and fully evaluate: 1, 2, 3, 4
- clinical trial and host direct: 1, 2, 3, 4
- clinical trial and level SARS viral load: 1
- clinical trial and monoclonal antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38
- clinical trial and poor prognosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- clinical trial and poor prognosis indicator: 1
- clinical trial and SARS viral load: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical trial and therapeutic target: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- clinical trial and viral load: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- critically ill patient and monoclonal antibody: 1, 2, 3
- critically ill patient and poor prognosis: 1, 2, 3, 4
- critically ill patient and viral load: 1
- critically ill patient mortality and poor prognosis: 1, 2
- fully evaluate and monoclonal antibody: 1
Co phrase search for related documents, hyperlinks ordered by date